Bangor Savings Bank Bristol Myers Squibb CO Transaction History

Bangor Savings Bank

$1.06 Billion
Q3 2024

A detailed history of Bangor Savings Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bangor Savings Bank holds 42,743 shares of BMY stock, worth $2.27 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

42,743

Previous 42,893 0.35%

Holding current value

$2.27 Million

Previous $1.78 Million 24.14%

% of portfolio

0.21%

Previous 0.18%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$39.66 - $51.75 $5,948 - $7,762	-150 Reduced 0.35%	42,743 $2.21 Million
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $189,054 - $248,894	-4,697 Reduced 9.87%	42,893 $1.78 Million
Q1 2024 Apr 11, 2024	SELL	$47.98 - $54.4 $301,362 - $341,686	-6,281 Reduced 11.66%	47,590 $2.58 Million
Q4 2023 Jan 16, 2024	BUY	$48.48 - $57.85 $73,932 - $88,221	1,525 Added 2.91%	53,871 $2.76 Million
Q3 2023 Oct 24, 2023	BUY	$57.89 - $64.73 $41,159 - $46,023	711 Added 1.38%	52,346 $3.04 Million
Q2 2023 Jul 07, 2023	BUY	$63.71 - $70.74 $45,361 - $50,366	712 Added 1.4%	51,635 $3.3 Million
Q1 2023 Apr 06, 2023	SELL	$65.71 - $74.53 $68,141 - $77,287	-1,037 Reduced 2.0%	50,923 $3.53 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $642,479 - $760,786	-9,382 Reduced 15.29%	51,960 $3.74 Million
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $68 - $40,571	528 Added 0.87%	61,342 $4.36 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $4.42 Million - $4.86 Million	60,814 New	60,814 $4.68 Million
Q1 2022 Apr 14, 2022	SELL	$61.48 - $73.72 $3.55 Million - $4.25 Million	-57,667 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$53.63 - $62.52 $268,632 - $313,162	5,009 Added 9.51%	57,667 $3.6 Million
Q3 2021 Oct 15, 2021	BUY	$59.17 - $69.31 $384,960 - $450,930	6,506 Added 14.1%	52,658 $3.12 Million
Q2 2021 Jul 23, 2021	BUY	$61.91 - $67.42 $10,029 - $10,922	162 Added 0.35%	46,152 $3.08 Million
Q1 2021 Apr 20, 2021	BUY	$59.34 - $66.74 $58,331 - $65,605	983 Added 2.18%	45,990 $2.9 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $87,129 - $98,733	-1,509 Reduced 3.24%	45,007 $2.79 Million
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $207,517 - $235,155	3,594 Added 8.37%	46,516 $2.99 Million
Q3 2020 Oct 06, 2020	SELL	$57.43 - $63.64 $70,753 - $78,404	-1,232 Reduced 2.79%	42,922 $2.59 Million
Q2 2020 Jul 08, 2020	SELL	$54.82 - $64.09 $21,270 - $24,866	-388 Reduced 0.87%	44,154 $2.6 Million
Q1 2020 Apr 06, 2020	SELL	$46.4 - $67.43 $91,593 - $133,106	-1,974 Reduced 4.24%	44,542 $2.48 Million
Q4 2019 Jan 07, 2020	BUY	$49.21 - $64.19 $321,144 - $418,903	6,526 Added 16.32%	46,516 $2.99 Million
Q3 2019 Oct 07, 2019	SELL	$42.77 - $50.71 $156,794 - $185,902	-3,666 Reduced 8.4%	39,990 $2.03 Million
Q2 2019 Jul 08, 2019	BUY	$44.62 - $49.34 $668,006 - $738,669	14,971 Added 52.19%	43,656 $1.98 Million
Q1 2019 Apr 08, 2019	BUY	$45.12 - $53.8 $812,566 - $968,884	18,009 Added 168.69%	28,685 $1.37 Million
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $71,530 - $92,758	-1,467 Reduced 12.08%	10,676 $555,000
Q3 2018 Oct 05, 2018	BUY	$55.19 - $62.25 $3,201 - $3,610	58 Added 0.48%	12,143 $754,000
Q2 2018 Jul 05, 2018	SELL	$50.53 - $62.98 $1,212 - $1,511	-24 Reduced 0.2%	12,085 $668,000
Q1 2018 Apr 23, 2018	BUY	$59.92 - $68.98 $39,487 - $45,457	659 Added 5.76%	12,109 $766,000
Q4 2017 Apr 23, 2018	BUY	$59.94 - $65.35 $71,388 - $77,831	1,191 Added 11.61%	11,450 $702,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $101,402 - $117,026	1,836 Added 21.8%	10,259 $654,000
Q2 2017 Aug 17, 2017	BUY	N/A	8,423	8,423 $470,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bangor Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bangor Savings Bank with notifications on news.

Account

Bangor Savings Bank Bristol Myers Squibb CO Transaction History